ASH Ashland Global Holdings Inc.

Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals

Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals

Technology successfully validated by field trials and successful customer pilots; commercial samples and material now available

Wilmington, Del., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Ashland has accelerated the application of the company’s new super wetting technology platform announced last September. The company has commercialized for corn, soy and wheat as well as watermelon, florals and other produce including bananas, lettuce, tomatoes and more.  Successful field trials and customer pilots over the last year validates Ashland’s strategy and demonstrates the company’s commitment to quickly scaling high-performance, innovative and sustainable technologies.

Easy-wet300 n is a biodegradable, nonionic, silicone-free, better processing and low-foaming wetting agent for crop formulations. Developed using proprietary, patented technology, easy-wet 300 n reduces spray drift beyond targeted crops and demonstrates superior effectiveness at lower concentrations in pesticide mixes. It provides better wettability than non-silicone, non-ionic surfactants (NIS). The product efficiently lowers water surface tension, ensuring full-coverage delivery of active ingredients smoothly across leaf surfaces.

Ashland’s technology enables agricultural retailers to improve their crop yields, unlocking organic growth.

Ashland’s innovative easy-wet 300 n wetting agent is biodegradable as defined by Organization for Economic Co-operation and Development (OECD) Test No. 302B. It is non-phytotoxic and enhances pesticide adhesion to leaves in a silicone free formulation with sustainable attributes.

“Last fall Ashland launched seven exciting, new technology platforms aligned to our core that could extend to secondary markets with new and differentiated capabilities,” said Alessandra Faccin, senior vice president and general manager, life sciences, Ashland. “Easy-wet 300 n wetting agent balances the age-old challenge of improving efficacy to feed more people by growing more crops on less land, with sustainable attributes that support our customers’ sustainability goals. This platform extension is a prime example of Ashland’s purpose to responsibly solve for a better world.”

“This new wetting agent offers high-value performance and allows customers precise control to fine-tune their formulations,” said Jean Jacques Gulka, business director, crop care, life sciences, Ashland.  “Our easy-wet 300 n wetting agent is water-soluble, waste-free, and biodegradable,” he concluded.

To learn more, discuss a trial and obtain a sample, visit

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social, and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. Approximately 3,800 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries. Visit and to learn more.

Trademark, Ashland, or its subsidiaries, registered in various countries.

Media Relations:  
Carolmarie Brown  
+1 (302) 995-3158  
 

Attachments



EN
16/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ashland Global Holdings Inc.

 PRESS RELEASE

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and...

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 202...

 PRESS RELEASE

Ashland to host 2025 Innovation Day for analysts and investors

Ashland to host 2025 Innovation Day for analysts and investors WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required, with options to attend via live webcast or in person. Participants will join Ashland’s executive and senior technology team for an in-depth review of the latest developments an...

 PRESS RELEASE

Ashland completes sale of Avoca business to Mane

Ashland completes sale of Avoca business to Mane Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of the transaction were not disclosed. The Avoca business supplies sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin.  The Avoca business line represents the last entity from Ashland’s previous acquisition of Pharmachem. “The Avoca business is a s...

Ashland Inc: 2 directors

Two Directors at Ashland Inc bought/maiden bought 34,444 shares at between 64.000USD and 64.240USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch